JPRN-UMIN000005251已完成未知
A prospective open-label study to investigate the efficacy and safety of methotrexate in Crohn's disease patients who lost response or showed intolerance to infliximab - Methotrexate in Crohn's disease patients who lost response or showed intolerance to infliximab
Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University0 个研究点目标入组 14 人开始时间: 2011年6月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Either patients who have ostomy who have obstructive symptoms who are complicated by severe infection such as abscess whoes white cell count is less than 3,000 whoes platelet count is less than 10,000 whoes Hb is less than 8.0g/dL who have severe cardiac disease who have severe renal disease who have severe liver disease such as AST or ALT level is above the upper normal limit liver cirrhosis who haves severe respiratory disease who are pregnant, or whoes partner is considering of pregnancy who started or increased the dosage of corticosteroids within 2 weeks before the study initiation who started or increase the dosage of immunomodulator (azathioprine or 6-mercaptopurine) within 2 weeks before the study initiation who are considered by study investigators to be inappropriate to be included in the study
研究者
相似试验
撤回
4 期
A prospective open-label study to investigate the effects of switching to a darunavir based regimen on low level viremia, immune activation and neurocognitive performance in patients on antiviral therapy.aidsHIV1002146010047438NL-OMON38997niversitair Medisch Centrum Utrecht65
已完成
4 期
A clinical trial to assess the frequency of "low sugar" in the mother with elevated sugars (during pregnancy) using insulin aspart.CTRI/2008/091/000070INVESTIGATOR INITIATED TRIA200
招募中
4 期
Efficacy and safety study of an Epoetin alfa in Thai patients under CAPD.Renal anemiarenal anemiaanemia in chronic kidney diseaseTCTR20140128002Apexcela, Co., Ltd.30
进行中（未招募）
不适用
Treatment of patients, who have Mucopolysaccharidosis Type I, receiving pentosan polysulfate subcutaneous injections weeklyMucopolysaccharidosis type I (alpha-L-Iduronidase deficiency)MedDRA version: 17.0Level: LLTClassification code 10056888Term: Mucopolysaccharidosis ISSystem Organ Class: 100000004850MedDRA version: 17.0Level: LLTClassification code 10056887Term: Mucopolysaccharidosis IH/SSystem Organ Class: 100000004850MedDRA version: 17.0Level: LLTClassification code 10028094Term: Mucopolysaccharidosis IHSystem Organ Class: 100000004850EUCTR2014-000350-11-DEMultiplex Pharma Holdings LLC6
已完成
不适用
An open-label study to investigate the effects of emvododstat on the pharmacokinetics of CYP2D6 and BCRP substrates in healthy volunteersCancerNL-OMON50753PTC Therapeutics, Inc.36